Skip to content

Relationship between dietary inflammation index and serum vitamin D in type 2 diabetes mellitus patients with nonalcoholic fatty liver disease

Relationship between dietary inflammation index and serum vitamin D in type 2 diabetes mellitus patients with nonalcoholic fatty liver disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400090251
Enrollment
Unknown
Registered
2024-09-26
Start date
2023-03-27
Completion date
Unknown
Last updated
2024-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-alcoholic fatty liver disease

Interventions

NAFLD+T2DM:None

Sponsors

Changzhou Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 78 Years

Inclusion criteria

Inclusion criteria: 1) Meet the diagnostic criteria for diabetes: ? patients with clinical symptoms of diabetes, with intravenous plasma blood glucose =11.1mmol/L(200mg/dL) and/or fasting plasma blood glucose =7.0mmol/L(126mg/dL) at any time; (2) Patients with no clinical symptoms of diabetes, only fasting intravenous plasma glucose =7.0mmol/L(126mg/dL) or random intravenous plasma glucose =11.1mmol/L(200mg/dL), and repeated measurements on another day still reach the upper value; ? If the blood glucose value is between the above two, oral glucose tolerance test should be performed. Results Plasma blood glucose =11.1mmol/L(200mg/dL) 2 hours after meals. 2) No history of excessive alcohol consumption (weekly alcohol consumption of < 210 g for men and < 140g for women in the past 12 months, that is, alcohol consumption equivalent to < 30 g/d for men and < 20 g/d for women). 3) Be able to understand the purpose of the survey, agree to participate in the study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1) Age < 18 years old; 2) Other specific liver diseases that can lead to fatty liver: alcoholic liver disease, viral hepatitis, autoimmune hepatitis, hepatolenticular degeneration, etc. 3) Drug-induced liver injury: acute and chronic liver injury caused by taking drugs that damage the liver (such as tamoxifen, ethamiodarone, sodium valproate, methotrexate, glucocorticoids, etc.). 4) Fatty liver caused by special conditions: total parenteral nutrition, inflammatory bowel disease, celiac disease, hypothyroidism, Cushing's syndrome, ß-lipoprotein deficiency, lipid atrophic diabetes, Mauriac syndrome, etc.

Design outcomes

Primary

MeasureTime frame
Serum 25(OH)D;

Secondary

MeasureTime frame
Macrobiochemistry;

Countries

China

Contacts

Public ContactWei Xiang

Changzhou Hospital of Traditional Chinese Medicine

Vivienne_xw@outlook.com+86 189 1502 9910

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026